Transforming-traditional-pharmaceutical-distribution-with-commerce-innovation: Difference between revisions

Article published by [[Other sources |Zaelab]] and reviewed by Nikolay Sidelnikov
(Created page with "{{#seo: |title=Review by B2B Experts |title_mode=append |keywords= digital, commerce, pharma, ecommerce |description= |image=Uploaded_file.png |image_alt=Wiki Logo }} {{Infobox article | source = https://www.zaelab.com/whitepaper/transforming-traditional-pharmaceutical-distribution-with-commerce-innovation | publisher = Zaelab | authors = Zaelab | publishdate = 2023 | topics = B2B eCommerce in Pharma | diagrams = No | numbers...")
 
No edit summary
Line 20: Line 20:
}}=== Abstract ===  
}}=== Abstract ===  


The article [https://www.zaelab.com/blogs/the-future-of-pharmaceutical-distribution The Future of Pharmaceutical Distribution] was published by Zaelab in 2023, and is devoted to pharmaceutical distribution predictions, and explains how technologies will change B2B interactions in the industry.  
The whitepaper [https://www.zaelab.com/whitepaper/transforming-traditional-pharmaceutical-distribution-with-commerce-innovation Transforming Traditional Pharmaceutical Distribution with Commerce Innovation] published by Zaelab in 2023 is a well structured and informative document that describes the critical capabilities enabling pharmaceutical organizations to disrupt their markets.  


In general, the author highlights two main trends:
You will need to leave your data to download the whitepaper on the company website.


* Pharmaceutical companies will move towards direct-to-consumer (DTC) distribution, especially for over-the-counter products, gaining control over brand presentation and customer experience.
The document contains the following information:
* They will streamline distribution processes and enhance transparency within the supply chain due to such technologies as artificial intelligence (AI), machine learning, and blockchain.


The following challenges are mentioned:
* Some insights on traditional pharmaceutical distribution models and its inefficiencies.
* The aspects that make pharmaceutical companies primed for disruption.
* The influence of B2B digital commerce evolution on pharmaceutical distribution and "the benefits behind the marriage of B2B ecommerce and pharmaceutical distribution"
* Technology infrastructure, key capabilities, and architectures that is preferable for pharmaceutical companies


* New technology requires aligning with existing heavy regulations and gaining approvals from regulatory bodies.
The whitepaper also contains a few mini case studies in the margin:
* Pharmaceutical companies handle sensitive patient data, intellectual property, and proprietary research information.


In addition to DTC trend, the route of how medications are accessed and distributed is changing. Online pharmacies offer patients greater convenience, a wider range of products, and direct access to pharmaceutical manufacturers or authorized distributors, leading to potential cost savings and more efficient inventory management.
* Streamlining sales process and improving customer satisfaction by a globally recognized pharmaceutical company.
* Expanding market reach and streamlining supply chain by a regional pharmaceutical distributor.


Another important trend is about creating a unified sales and marketing strategy, that would ensure a consistent message across all stakeholder touchpoints.


Full article: [https://www.zaelab.com/whitepaper/transforming-traditional-pharmaceutical-distribution-with-commerce-innovation Transforming Traditional Pharmaceutical Distribution with Commerce Innovation]
The whitepaper is available here: [https://www.zaelab.com/whitepaper/transforming-traditional-pharmaceutical-distribution-with-commerce-innovation Transforming Traditional Pharmaceutical Distribution with Commerce Innovation]





Revision as of 10:41, 10 April 2024

Transforming Traditional Pharmaceutical Distribution with Commerce Innovation (with abstract)
Published By[[Zaelab]]
Publish Date2023
AuthorsZaelab
Topics B2B eCommerce in Pharma
Statistics
Article Sizewords
DiagramsNo
Downloadable VersionNo
Reviewers
Page OwnerNikolay Sidelnikov
Summary AuthorNikolay Sidelnikov


Abstract

The whitepaper Transforming Traditional Pharmaceutical Distribution with Commerce Innovation published by Zaelab in 2023 is a well structured and informative document that describes the critical capabilities enabling pharmaceutical organizations to disrupt their markets.

You will need to leave your data to download the whitepaper on the company website.

The document contains the following information:

  • Some insights on traditional pharmaceutical distribution models and its inefficiencies.
  • The aspects that make pharmaceutical companies primed for disruption.
  • The influence of B2B digital commerce evolution on pharmaceutical distribution and "the benefits behind the marriage of B2B ecommerce and pharmaceutical distribution"
  • Technology infrastructure, key capabilities, and architectures that is preferable for pharmaceutical companies

The whitepaper also contains a few mini case studies in the margin:

  • Streamlining sales process and improving customer satisfaction by a globally recognized pharmaceutical company.
  • Expanding market reach and streamlining supply chain by a regional pharmaceutical distributor.


The whitepaper is available here: Transforming Traditional Pharmaceutical Distribution with Commerce Innovation


Subscribe to B2B Experts Digest

Contribute to B2B Experts Community